Emmaus Life Sciences, Inc.
EMMA
$0.0115
-$0.0024-17.27%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 17.08% | -26.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.08% | -26.91% | |||
| Cost of Revenue | -33.33% | -27.18% | |||
| Gross Profit | 22.28% | -26.89% | |||
| SG&A Expenses | -0.13% | -12.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.88% | -12.03% | |||
| Operating Income | 62.24% | -75.94% | |||
| Income Before Tax | 25.84% | -33.52% | |||
| Income Tax Expenses | -14,850.00% | -33.33% | |||
| Earnings from Continuing Operations | 51.29% | -33.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.29% | -33.30% | |||
| EBIT | 62.24% | -75.94% | |||
| EBITDA | 62.46% | -76.63% | |||
| EPS Basic | 51.23% | -33.21% | |||
| Normalized Basic EPS | 15.09% | -24.71% | |||
| EPS Diluted | 51.23% | -14.06% | |||
| Normalized Diluted EPS | 15.09% | -24.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||